Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

BASF describes new, selective ECE inhibitors

May 25, 1999

Glaxo Wellcome launches first drug to treat PPH in Japan

May 25, 1999

MediGene discovers target gene for DCM therapy

May 24, 1999

Warner-Lambert presents new MMP inhibitors and their use

May 20, 1999

FDA allows LXR Biotechnology's IND for CP-Cardiosol

May 20, 1999

Avalide now available in U.S. for hypertension

May 20, 1999

Azimilide reduces recurrence in PSVT patients

May 19, 1999

Phospholamban inhibitors described by Orion for use in heart failure

May 18, 1999

Neuropeptide Y antagonists specifically claimed for use in cardiovascular disorders

May 17, 1999

DSMB approves continuation of phase III trial of Flocor in sickle cell crisis

May 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...